Ignite Creation Date:
2024-05-06 @ 1:17 PM
Last Modification Date:
2024-10-26 @ 1:11 PM
Study NCT ID:
NCT03979131
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2023-04-26
First Post:
2019-06-06
Brief Title:
Phase II Study of Avelumab Plus Chemotherapy in the Peri-operative Treatment for Patients With Resectable Gastric Cancer GC or Gastroesophageal Junction Cancer GEJC
Sponsor:
Vall dHebron Institute of Oncology
Organization:
Vall dHebron Institute of Oncology
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-08-22
Start Date Type:
ACTUAL
Primary Completion Date:
2023-03-15
Primary Completion Date Type:
ACTUAL
Completion Date:
2026-06-15
Completion Date Type:
ESTIMATED
First Submit Date:
2019-06-06
First Submit QC Date:
June 6 2019
Study First Post Date:
2019-06-07
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-04-25
Last Update Post Date:
2023-04-26
Last Update Post Date Type:
ACTUAL